Erratum: ZFC3H1, a zinc finger protein, modulates IL-8 transcription by binding with celastramycin A, a potential immune suppressor (PLoS ONE (2014) 9:9 (E108957) DOI: 10.1371/journal.pone.0108957);ZFC3H1, a zinc finger protein, modulates IL-8 transcription by binding with celastramycin A, a potential immune suppressor

PLoS ONE

Volumn 9, Issue 9, 2014, Pages

  Tomita, Takeshi ^a   Ieguchi, Katsuaki ^a   Coin, Fredric ^b   Kato, Yasuhiro ^c   Kikuchi, Haruhisa ^c   Oshima, Yoshiteru ^c   Kurata, Shoichiro ^c   Maru, Yoshiro ^a  

^a TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

^b UNIVERSITÉ DE STRASBOURG   (France)

^c TOHOKU UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BIOTINYLATED CELASTRAMYCIN A; CELASTRAMYCIN A; CELASTRAMYCIN A AMIDE; EXCISION REPAIR CROSS COMPLEMENTING PROTEIN 1; IMMUNOSUPPRESSIVE AGENT; INTERLEUKIN 8; PROTEIN ZFC3H1; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; ZINC FINGER PROTEIN; DNA BINDING PROTEIN; ENDONUCLEASE; ERCC1 PROTEIN, HUMAN; PHOSPHOPROTEIN; PROTEIN BINDING; PYRROLE DERIVATIVE; RESORCINOL DERIVATIVE; SMALL INTERFERING RNA; TRANSCRIPTION FACTOR; ZFC3H1 PROTEIN, HUMAN;

ARTICLE; CONTROLLED STUDY; DNA REPAIR; DRUG PROTEIN BINDING; DRUG STRUCTURE; EMBRYO; HUMAN; HUMAN CELL; IL 8 GENE; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; TRANSCRIPTION INITIATION; TRANSCRIPTION REGULATION; ULTRAVIOLET RADIATION; ANTAGONISTS AND INHIBITORS; CHEMISTRY; DRUG EFFECTS; GENE EXPRESSION; GENETICS; HELA CELL LINE; METABOLISM; RADIATION RESPONSE; RNA INTERFERENCE; RNA STABILITY; SIGNAL TRANSDUCTION; TUMOR CELL LINE;

CELL LINE, TUMOR; DNA-BINDING PROTEINS; ENDONUCLEASES; GENE EXPRESSION; HELA CELLS; HUMANS; INTERLEUKIN-8; PHOSPHOPROTEINS; PROTEIN BINDING; PYRROLES; RESORCINOLS; RNA INTERFERENCE; RNA STABILITY; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION; TRANSCRIPTION FACTORS; TRANSCRIPTIONAL ACTIVATION; TUMOR NECROSIS FACTOR-ALPHA; ULTRAVIOLET RAYS;

EID: 84907481745     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0138262     Document Type: Erratum

References (24)

1. Zhu J, Smith K, Hsieh PN, Mburu YK, Chattopadhyay S, et al. (2010) Highthroughput screening for TLR3-IFN regulatory factor 3 signaling pathway modulators identifies several antipsychotic drugs as TLR inhibitors. J Immunol 184: 5768-5776. doi: 10.4049/jimmunol.0903559. PubMed: 20382888.
2. Dayer J-M, Molnarfi N, Burger D (2005) From cellular receptors to transduction-transcription pathways for cytokines: at which level should the inhibition be targeted in inflammation? Expert Opin Biol Ther 5: S83-S96. PubMed: 16187943.
3. Keogh B, Parker AE (2011) Toll-like receptors as targets for immune disorders. Trends Pharmacol Sci 32: 435-442. doi: 10.1016/j.tips.2011.03.008. PubMed: 21529972.
4. Liu X, Zheng J, Zhou H (2011) TLRs as pharmacological targets for plant-derived compounds in infectious and inflammatory diseases. Int Immunopharmacol 11: 1451-1456. doi: 10.1016/j.intimp.2011.04.027. PubMed: 21586344.
5. Midwood K, Sacre S, Piccinini AM, Inglis J, Trebaul A, et al. (2009) Tenascin-C is an endogenous activator of Toll-like receptor 4 that is essential for maintaining inflammation in arthritic joint disease. Nat Med 15: 774-780. doi: 10.1038/nm.1987. PubMed: 19561617.
6. McInnes IB, O'Dell JR (2010) State-of-the-art: rheumatoid arthritis. Ann Rheum Dis 69: 1898-1906. doi: 10.1136/ard.2010.134684. PubMed: 20959326.
7. Pal D, Dasgupta S, Kundu R, Maitra S, Das G, et al. (2012) Fetuin - A acts as an endogenous ligand of TLR4 to promote lipid-induced insulin resistance. Nat Med 18: 1279-1285. doi: 10.1038/nm.2851. PubMed: 22842477.
8. Kim JK (2006) Fat uses a TOLL-road to connect inflammation and diabetes. Cell Metab 4: 417-419. PubMed: 17141623.
9. Balkwill F (2009) Tumour necrosis factor and cancer. Nat Rev Cancer 9: 361-371. doi: 10.1038/nrc2628. PubMed: 19343034.
10. Kim S, Takahashi H, Lin WW, Descargues P, Grivennikov S, et al. (2009) Carcinoma-produced factors activate myeloid cells through TLR2 to stimulate metastasis. Nature 457: 102-106. doi: 10.1038/nature07623. PubMed: 19122641.
11. Hiratsuka S, Watanabe A, Aburatani H, Maru Y (2006) Tumor-mediated upregulation of chemoattractants and recruitment of myeloid cells predetermines lung metastasis. Nat Cell Biol 8: 1369-1375. PubMed: 17128264.
12. Hiratsuka S, Watanabe A, Sakurai Y, Akashi-Takamura S, Ishibashi S, et al. (2008) The S100A8-serum amyloid A3-TLR4 paracrine cascade establishes a pre-metastatic phase. Nat Cell Biol 10: 1349-1355. doi: 10.1038/ncb1794. PubMed: 18820689.
13. Tomita T, Sakurai Y, Ishibashi S, Maru Y (2011) Imbalance of Clara cellmediated homeostatic inflammation is involved in lung metastasis. Oncogene 30:3429-3439. doi: 10.1038/onc.2011.53. PubMed: 21399660.
14. Yajima M, Takada M, Takahashi N, Kikuchi H, Natori S, et al. (2003) A newly established in vitro culture using transgenic Drosophila reveals functional coupling between the phospholipase A2-generated fatty acid cascade and lipopolysaccharide-dependent activation of the immune deficiency (imd) pathway in insect immunity. Biochem J 371(Pt 1): 205-10. PubMed: 12513692.
15. Kikuchi H, Sekiya M, Katou Y, Ueda K, Kabeya T, et al.(2009) Revised structure and synthesis of celastramycin a, a potent innate immune suppressor. Org Lett 11: 1693-1695. doi: 10.1021/ol9002306. PubMed: 19317429.
16. Mukaida N, Morita M, Ishikawa Y, Rice N, Okamoto S, et al. (1994) Novel mechanism of glucocorticoid-mediated gene repression. Nuclear factor-kappa B is target for glucocorticoid-mediated interleukin 8 gene repression. J Biol Chem 269: 13289-13295. PubMed: 8175759.
17. Abe S, Nakamura H, Inoue S, Takeda H, Saito H, et al. (2000) Interleukin-8 gene repression by clarithromycin is mediated by the activator protein-1 binding site in human bronchial epithelial cells. Am J Respir Cell Mol Biol 22: 51-60. PubMed: 10615065.
18. Bezzerri V, Borgatti M, Finotti A, Tamanini A, Gambari R, et al. (2011) Mapping the transcriptional machinery of the IL-8 gene in human bronchial epithelial cells. J Immunol 187:6069-6081. doi: 10.4049/jimmunol.1100821. PubMed: 22031759.
19. Villarete LH, Remick DG (1996) Transcriptional and post-transcriptional regulation of interleukin-8. Am J Pathol 149:1685-93. PubMed: 8909257.
20. Singh RK, Gutman M, Reich R, Bar-Eli M (1995) Ultraviolet B irradiation promotes tumorigenic and metastatic properties in primary cutaneous melanoma via induction of interleukin 8. Cancer Res 55: 3669-3674. PubMed: 7543020.
21. Aboussekhra A, Biggerstaff M, Shivji MK, Vilpo JA, Moncollin V, et al. (1995) Mammalian DNA nucleotide excision repair reconstituted with purified protein components. Cell 80: 859-868. PubMed: 7697716.
22. Araújo SJ, Tirode F, Coin F, Pospiech H, Syväoja JE, et al. (2000) Nucleotide excision repair of DNA with recombinant human proteins: definition of the minimal set of factors, active forms of TFIIH, and modulation by CAK. Genes Dev 14: 349-359. PubMed: 10673506.
23. Schweiger R, Soll J, Jung K, Heermann R, Schwenkert S (2013) Quantification of interaction strengths between chaperones and tetratricopeptide repeat domain containing membrane proteins. J Biol Chem 288: 30614-25. doi: 10.1074/jbc.M113.493015. PubMed: 24036116.
24. Champion EA, Lane BH, Jackrel ME, Regan L, Baserga SJ (2008) A direct interaction between the Utp6 half-a-tetratricopeptide repeat domain and a specific peptide in Utp21 is essential for efficient pre-rRNA processing. Mol Cell Biol 28: 6547-6456. doi: 10.1128/MCB.00906-08. PubMed: 18725399.